GeraClinic / NHS cancer waiting times / NHS Bristol, North Somerset And South Gloucestershire ICB
NHS Bristol, North Somerset And South Gloucestershire ICB: NHS Cancer Waiting Times
In April 2026, 70.3% of cancer patients in NHS Bristol, North Somerset And South Gloucestershire ICB started treatment within 62 days of urgent referral — 0.5 percentage points above the England average. Gera Cancer Pathway Pressure Index: 18.6/100 (below-average pathway pressure). Official NHS England data.
What is the NHS cancer waiting time in NHS Bristol, North Somerset And South Gloucestershire ICB?
As of April 2026, 70.3% of cancer patients in NHS Bristol, North Somerset And South Gloucestershire ICB started treatment within 62 days of urgent referral — 0.5 percentage points above the England average (NHS target: 85%) — covering 501 patients, per NHS England Cancer Waiting Times data published June 2026. Gera re-dates this monthly.
The GCPPI for NHS Bristol, North Somerset And South Gloucestershire ICB = (1 − 70.3% / 100) × 4,585 FDS referrals = raw pressure 1362, normalised to 18.6/100. Rank 30 of 36 ICBs (rank 1 = most pressure). See methodology.
| Measure | NHS Bristol, North Somerset And South Gloucestershire ICB | What it means |
|---|---|---|
| 62-day standard met | 70.3% | NHS target: 85% |
| 28-day FDS met | 81.4% | NHS target: 75% |
| Patients in 62-day pathway | 501 | All four 62-day sub-pathways |
| FDS referral volume | 4,585 | Faster Diagnosis Standard demand |
| Gera Pressure Index (GCPPI) | 18.6 / 100 | below-average pathway pressure |
| Pathway pressure rank | 30 / 36 | Rank 1 = most pressure in England |
| Pathway | Patients | 62-day met | Standard |
|---|---|---|---|
| Urgent Suspected Cancer | 259 | 62.2% | Missed |
| Screening | 47 | 61.7% | Missed |
| Consultant Upgrade | 195 | 83.1% | Missed |
Check your area's cancer pathway pressure
Compare NHS Bristol, North Somerset And South Gloucestershire ICB with other ICBs — real NHS data, updated monthly
Compare cancer waiting times in other areas
Sorted by Gera Cancer Pathway Pressure Index (highest pressure first).
- NHS Surrey And Sussex ICB (GCPPI 100)
- NHS Essex ICB (GCPPI 93.4)
- NHS North East And North Cumbria ICB (GCPPI 75.5)
- NHS West And North London ICB (GCPPI 68.7)
- NHS Central East ICB (GCPPI 68.3)
- NHS Lancashire And South Cumbria ICB (GCPPI 63.6)
- NHS Greater Manchester ICB (GCPPI 62.9)
- NHS Cheshire And Merseyside ICB (GCPPI 61.2)
- NHS Norfolk And Suffolk ICB (GCPPI 55.5)
- NHS Thames Valley ICB (GCPPI 55.3)
- NHS South East London ICB (GCPPI 50.5)
- NHS West Yorkshire ICB (GCPPI 48.8)
- All 36 ICBs & the England average →
NHS Bristol, North Somerset And South Gloucestershire ICB cancer waiting times: FAQs
- What is the NHS cancer 62-day waiting time in NHS Bristol, North Somerset And South Gloucestershire ICB?
- In April 2026, 70.3% of cancer patients in NHS Bristol, North Somerset And South Gloucestershire ICB started treatment within 62 days of urgent referral — 0.5 percentage points above the England average. The NHS target is 85%. Data: NHS England Cancer Waiting Times.
- What is the Gera Cancer Pathway Pressure Index for NHS Bristol, North Somerset And South Gloucestershire ICB?
- The Gera Cancer Pathway Pressure Index (GCPPI) for NHS Bristol, North Somerset And South Gloucestershire ICB in April 2026 is 18.6/100 (below-average pathway pressure). It is computed as (1 − 62-day standard met rate) × referral volume, normalised across all 36 ICBs. NHS Bristol, North Somerset And South Gloucestershire ICB ranks 30 of 36 ICBs by pathway pressure.
- How does NHS Bristol, North Somerset And South Gloucestershire ICB compare on the 28-day Faster Diagnosis Standard?
- In April 2026, 81.4% of patients in NHS Bristol, North Somerset And South Gloucestershire ICB received a cancer diagnosis or ruling-out within 28 days (NHS FDS target: 75%). NHS Bristol, North Somerset And South Gloucestershire ICB processed 4,585 FDS referrals in this period, per NHS England Cancer Waiting Times data.
- Can I be seen privately while waiting for cancer assessment in NHS Bristol, North Somerset And South Gloucestershire ICB?
- Yes. Being assessed or treated privately does not affect your NHS referral. GeraClinic can connect you to a UK-registered cancer specialist. You keep your place on the NHS list and can access a private consultation simultaneously.
- What are the main cancer pathways in NHS Bristol, North Somerset And South Gloucestershire ICB?
- The NHS 62-day standard in NHS Bristol, North Somerset And South Gloucestershire ICB covers four pathways: Urgent Suspected Cancer (the primary 2-week-wait route), Screening (referrals from NHS screening programmes), Consultant Upgrade (reclassification onto the 62-day pathway by a clinician), and Breast Symptomatic (non-2WW breast referrals). In April 2026, NHS Bristol, North Somerset And South Gloucestershire ICB recorded 501 patients across all four pathways.
NHS Bristol, North Somerset And South Gloucestershire ICB is below the NHS 85% cancer target
Only 70.3% of cancer patients in NHS Bristol, North Somerset And South Gloucestershire ICB met the 62-day standard in April 2026 (NHS target: 85%). GeraClinic can connect you to a UK-registered cancer specialist quickly — you keep your NHS referral while getting faster private assessment.
Data and methodology
Figures for NHS Bristol, North Somerset And South Gloucestershire ICB are aggregated from the real per-sub-location count rows in NHS England's April 2026 Cancer Waiting Times ICB Sub-Location extract. Each sub-location code (e.g. multiple [ICB sub-location codes, NHS ODS]) is mapped to its parent ICB via the NHS Organisation Data Service and summed for both the 62-day Combined and 28-day FDS standards. Percentages are re-derived from summed numerators and denominators — not averaged. The Gera Cancer Pathway Pressure Index = (1 − 62-day met rate) × referral volume, normalised 0–100. No estimates or invented numbers. See full methodology.
Contains public sector information published by NHS England and licensed under the Open Government Licence v3.0.